BCBSM is ending coverage of select brand-name prescription drugs for BCBSM commercial (non-Medicare) members.
The following drugs are not approved by the U. S. Food and Drug Administration. Therefore, beginning July 1, 2012, BCBSM will no longer cover these brand-name products:
|
Brand name products
|
|
First – BXN Mouthwash compounding kit |
| First – Duke’s |
| First – Hydrocortisone |
| First – Lansoprazole |
| First – Mary’s |
| First – Mouthwash BLM |
| First – Omeprazole |
| First – Progesterone MC |
| First – Progesterone VGS |
| First – Testosterone |
| Umecta PD |
The decision to end coverage for these products is in accordance with BCBSM pharmacy benefit agreements that only provide coverage for drugs approved by the FDA. As a BCBSM/BCN member, you should receive the following letter from BCBSM, outlining the changes and listing the effected drugs: Member (PDF).
Members are advised to discuss formulary alternatives with their physician. As always, please contact your AFG Account Manager with questions.
All content provided on this blog is for informational purposes only. The owner of this blog makes no representations as to the accuracy or completeness of any information on this site or found by following any link on this site. The owner of this blog does not endorse any of the information in this blog and it does not reflect the opinions of Austin Financial Group. The owner will not be liable for any errors or omissions in this information nor for the availability of this information. The owner will not be liable for any losses, injuries, or damages from the display or use of this information.
